EGFR and non-small cell lung carcinoma: Moreover, epiregulin expression is associated with lymph node metastasis and shortened survival in NSCLC, and the invasiveness of NSCLC cell lines with activating EGFR mutations can be reduced by silencing epiregulin or by using antibody treatments [73, 74].